Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Jan 1;345(Pt 1):25–32.

Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.

A Hammacher 1, J Wijdenes 1, D J Hilton 1, N A Nicola 1, R J Simpson 1, J E Layton 1
PMCID: PMC1220726  PMID: 10600635

Abstract

The receptor gp130 is used by the interleukin-6 (IL-6)-type cytokines, which include IL-6 and leukaemia-inhibitory factor (LIF). To investigate the role of the three extracellular membrane-proximal fibronectin-type-III-like (FNIII) modules of gp130 and the related receptor for granulocyte colony-stimulating factor (G-CSFR) in cytokine signal transduction we have transfected into murine myeloid M1-UR21 cells the chimaera (GR-FNIII)gp130, which contains the membrane-proximal FNIII modules of the G-CSFR on a gp130 backbone, and its complement, the chimaera (gp130-FNIII)GR. Whereas the binding affinities of (125)I-labelled IL-6 to (GR-FNIII)gp130, or of (125)I-Tyr1,3-G-CSF to (gp130-FNIII)GR, were similar to wild-type gp130 and wild-type G-CSFR, respectively, (125)I-LIF failed to bind with high affinity to (GR-FNIII)gp130. In assays measuring differentiation the (gp130-FNIII)GR cells were fully responsive to G-CSF, whereas the (GR-FNIII)gp130 cells responded fully to the agonistic anti-gp130 monoclonal antibody (mAb) B-S12, but not to IL-6 or LIF. Neutralizing mAbs that recognize the membrane-proximal FNIII modules of gp130 or the G-CSFR differentially interfered with signalling by B-S12, LIF and G-CSF. The data suggest that B-S12 and G-CSF induce the correct orientation or conformation for signalling by the wild-type and chimaeric homodimeric receptors, that the membrane-proximal region of gp130 is important for the correct formation of the signalling IL-6-IL-6 receptor-gp130 complex and that this region is also involved in LIF-dependent receptor heterodimerization and signalling.

Full Text

The Full Text of this article is available as a PDF (190.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. doi: 10.1016/s0065-2776(08)60532-5. [DOI] [PubMed] [Google Scholar]
  2. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934–6938. doi: 10.1073/pnas.87.18.6934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Calvo J. C., Radicella J. P., Charreau E. H. Measurement of specific radioactivities in labelled hormones by self-displacement analysis. Biochem J. 1983 May 15;212(2):259–264. doi: 10.1042/bj2120259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chevalier S., Fourcin M., Robledo O., Wijdenes J., Pouplard-Barthelaix A., Gascan H. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. J Biol Chem. 1996 Jun 21;271(25):14764–14772. doi: 10.1074/jbc.271.25.14764. [DOI] [PubMed] [Google Scholar]
  5. Cunningham B. C., Ultsch M., De Vos A. M., Mulkerrin M. G., Clauser K. R., Wells J. A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 1991 Nov 8;254(5033):821–825. doi: 10.1126/science.1948064. [DOI] [PubMed] [Google Scholar]
  6. Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 1993 Jun 18;260(5115):1805–1808. doi: 10.1126/science.8390097. [DOI] [PubMed] [Google Scholar]
  7. Fourcin M., Chevalier S., Guillet C., Robledo O., Froger J., Pouplard-Barthelaix A., Gascan H. gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses. J Biol Chem. 1996 May 17;271(20):11756–11760. doi: 10.1074/jbc.271.20.11756. [DOI] [PubMed] [Google Scholar]
  8. Fukunaga R., Ishizaka-Ikeda E., Pan C. X., Seto Y., Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 1991 Oct;10(10):2855–2865. doi: 10.1002/j.1460-2075.1991.tb07835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. doi: 10.1126/science.1542794. [DOI] [PubMed] [Google Scholar]
  10. Hammacher A., Richardson R. T., Layton J. E., Smith D. K., Angus L. J., Hilton D. J., Nicola N. A., Wijdenes J., Simpson R. J. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J Biol Chem. 1998 Aug 28;273(35):22701–22707. doi: 10.1074/jbc.273.35.22701. [DOI] [PubMed] [Google Scholar]
  11. Hammacher A., Ward L. D., Weinstock J., Treutlein H., Yasukawa K., Simpson R. J. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Protein Sci. 1994 Dec;3(12):2280–2293. doi: 10.1002/pro.5560031213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990 Dec 21;63(6):1149–1157. doi: 10.1016/0092-8674(90)90411-7. [DOI] [PubMed] [Google Scholar]
  13. Hilton D. J., Hilton A. A., Raicevic A., Rakar S., Harrison-Smith M., Gough N. M., Begley C. G., Metcalf D., Nicola N. A., Willson T. A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994 Oct 17;13(20):4765–4775. doi: 10.1002/j.1460-2075.1994.tb06802.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hilton D. J., Nicola N. A. Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution. J Biol Chem. 1992 May 25;267(15):10238–10247. [PubMed] [Google Scholar]
  15. Hiraoka O., Anaguchi H., Asakura A., Ota Y. Requirement for the immunoglobulin-like domain of granulocyte colony-stimulating factor receptor in formation of a 2:1 receptor-ligand complex. J Biol Chem. 1995 Oct 27;270(43):25928–25934. doi: 10.1074/jbc.270.43.25928. [DOI] [PubMed] [Google Scholar]
  16. Horan T. P., Martin F., Simonet L., Arakawa T., Philo J. S. Dimerization of granulocyte-colony stimulating factor receptor: the Ig plus CRH construct of granulocyte-colony stimulating factor receptor forms a 2:2 complex with a ligand. J Biochem. 1997 Feb;121(2):370–375. doi: 10.1093/oxfordjournals.jbchem.a021597. [DOI] [PubMed] [Google Scholar]
  17. Horan T., Wen J., Narhi L., Parker V., Garcia A., Arakawa T., Philo J. Dimerization of the extracellular domain of granuloycte-colony stimulating factor receptor by ligand binding: a monovalent ligand induces 2:2 complexes. Biochemistry. 1996 Apr 16;35(15):4886–4896. doi: 10.1021/bi9525841. [DOI] [PubMed] [Google Scholar]
  18. Horsten U., Müller-Newen G., Gerhartz C., Wollmer A., Wijdenes J., Heinrich P. C., Grötzinger J. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J Biol Chem. 1997 Sep 19;272(38):23748–23757. doi: 10.1074/jbc.272.38.23748. [DOI] [PubMed] [Google Scholar]
  19. Horsten U., Schmitz-Van de Leur H., Müllberg J., Heinrich P. C., Rose-John S. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett. 1995 Feb 20;360(1):43–46. doi: 10.1016/0014-5793(95)00053-c. [DOI] [PubMed] [Google Scholar]
  20. Ishizaka-Ikeda E., Fukunaga R., Wood W. I., Goeddel D. V., Nagata S. Signal transduction mediated by growth hormone receptor and its chimeric molecules with the granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):123–127. doi: 10.1073/pnas.90.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Johnson D. L., Farrell F. X., Barbone F. P., McMahon F. J., Tullai J., Hoey K., Livnah O., Wrighton N. C., Middleton S. A., Loughney D. A. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry. 1998 Mar 17;37(11):3699–3710. doi: 10.1021/bi971956y. [DOI] [PubMed] [Google Scholar]
  22. Larsen A., Davis T., Curtis B. M., Gimpel S., Sims J. E., Cosman D., Park L., Sorensen E., March C. J., Smith C. A. Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J Exp Med. 1990 Dec 1;172(6):1559–1570. doi: 10.1084/jem.172.6.1559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Layton J. E., Iaria J., Nicholson S. E. Neutralising antibodies to the granulocyte colony-stimulating factor receptor recognise both the immunoglobulin-like domain and the cytokine receptor homologous domain. Growth Factors. 1997;14(2-3):117–130. doi: 10.3109/08977199709021515. [DOI] [PubMed] [Google Scholar]
  24. Layton J. E., Iaria J., Smith D. K., Treutlein H. R. Identification of a ligand-binding site on the granulocyte colony-stimulating factor receptor by molecular modeling and mutagenesis. J Biol Chem. 1997 Nov 21;272(47):29735–29741. doi: 10.1074/jbc.272.47.29735. [DOI] [PubMed] [Google Scholar]
  25. Lieschke G. J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K. J., Basu S., Zhan Y. F., Dunn A. R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994 Sep 15;84(6):1737–1746. [PubMed] [Google Scholar]
  26. Mizushima S., Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 1990 Sep 11;18(17):5322–5322. doi: 10.1093/nar/18.17.5322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Moore P. S., Boshoff C., Weiss R. A., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 1996 Dec 6;274(5293):1739–1744. doi: 10.1126/science.274.5293.1739. [DOI] [PubMed] [Google Scholar]
  28. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L. S., Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996 Dec 20;271(51):32635–32643. doi: 10.1074/jbc.271.51.32635. [DOI] [PubMed] [Google Scholar]
  29. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 1993 Jun 18;260(5115):1808–1810. doi: 10.1126/science.8511589. [DOI] [PubMed] [Google Scholar]
  30. Salvati A. L., Lahm A., Paonessa G., Ciliberto G., Toniatti C. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. J Biol Chem. 1995 May 19;270(20):12242–12249. doi: 10.1074/jbc.270.20.12242. [DOI] [PubMed] [Google Scholar]
  31. Simpson R. J., Hammacher A., Smith D. K., Matthews J. M., Ward L. D. Interleukin-6: structure-function relationships. Protein Sci. 1997 May;6(5):929–955. doi: 10.1002/pro.5560060501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Smith D. K., Treutlein H. R. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding. Protein Sci. 1998 Apr;7(4):886–896. doi: 10.1002/pro.5560070406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Syed R. S., Reid S. W., Li C., Cheetham J. C., Aoki K. H., Liu B., Zhan H., Osslund T. D., Chirino A. J., Zhang J. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 1998 Oct 1;395(6701):511–516. doi: 10.1038/26773. [DOI] [PubMed] [Google Scholar]
  34. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15:797–819. doi: 10.1146/annurev.immunol.15.1.797. [DOI] [PubMed] [Google Scholar]
  35. Tian S. S., Lamb P., King A. G., Miller S. G., Kessler L., Luengo J. I., Averill L., Johnson R. K., Gleason J. G., Pelus L. M. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science. 1998 Jul 10;281(5374):257–259. doi: 10.1126/science.281.5374.257. [DOI] [PubMed] [Google Scholar]
  36. Watanabe M., Fukamachi H., Uzumaki H., Kabaya K., Tsumura H., Ishikawa M., Matsuki S., Kusaka M. Mutant protein of recombinant human granulocyte colony-stimulating factor for receptor binding assay. Anal Biochem. 1991 May 15;195(1):38–44. doi: 10.1016/0003-2697(91)90291-z. [DOI] [PubMed] [Google Scholar]
  37. Wijdenes J., Heinrich P. C., Müller-Newen G., Roche C., Gu Z. J., Clément C., Klein B. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur J Immunol. 1995 Dec;25(12):3474–3481. doi: 10.1002/eji.1830251240. [DOI] [PubMed] [Google Scholar]
  38. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science. 1988 Aug 12;241(4867):825–828. doi: 10.1126/science.3136546. [DOI] [PubMed] [Google Scholar]
  39. Yasukawa K., Futatsugi K., Saito T., Yawata H., Narazaki M., Suzuki H., Taga T., Kishimoto T. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol Lett. 1992 Feb;31(2):123–130. doi: 10.1016/0165-2478(92)90138-e. [DOI] [PubMed] [Google Scholar]
  40. Zhang J. G., Moritz R. L., Reid G. E., Ward L. D., Simpson R. J. Purification and characterization of a recombinant murine interleukin-6. Isolation of N- and C-terminally truncated forms. Eur J Biochem. 1992 Aug 1;207(3):903–913. doi: 10.1111/j.1432-1033.1992.tb17123.x. [DOI] [PubMed] [Google Scholar]
  41. Zhang J. G., Zhang Y., Owczarek C. M., Ward L. D., Moritz R. L., Simpson R. J., Yasukawa K., Nicola N. A. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J Biol Chem. 1998 Apr 24;273(17):10798–10805. doi: 10.1074/jbc.273.17.10798. [DOI] [PubMed] [Google Scholar]
  42. de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992 Jan 17;255(5042):306–312. doi: 10.1126/science.1549776. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES